At present, Beijing Hospital has three kinds of anti-VEGF drugs: razumab (imported), abciximab (imported), and Compazepine (domestic) Beijing Hospital is the first hospital in China to carry out intraocular drug injection for the following diseases, and this year, the latest imported abciximab drug was introduced. Intraocular injection of anti-VEGF drugs is suitable for the following diseases: 1. wet age-related macular degeneration 2. retinal static obstruction combined with macular edema 3. diabetic retinopathy combined with macular edema 4. intermediate infiltration 5. high myopia secondary to choroidal neovascularization 6. macular choroidal neovascularization secondary to other diseases 7. macular edema secondary to other diseases 8. neovascular glaucoma 9. proliferative diabetes mellitus Retinopathy (vitreous hemorrhage) 10, chronic mesoplasia, etc.